Spots Global Cancer Trial Database for casodex
Every month we try and update this database with for casodex cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Casodex - Nolvadex Combination | NCT00637871 | Gynaecomastia Prostate Cancer | Casodex Tamoxifen | - | AstraZeneca | |
| Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients | NCT03650894 | Breast Neoplasm... Breast Cancer Breast Carcinom... Breast Tumor | Nivolumab Ipilimumab Bicalutamide | 18 Years - | Providence Health & Services | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | NCT00631527 | Prostate Cancer | Leuprolide Goserelin Sunitinib Malat... Casodex Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX | NCT00590213 | Prostate Cancer | Casodex 150mg Radiotherapy Haematology | 18 Years - | AstraZeneca | |
| Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | NCT00850941 | Prostate Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer | NCT00636259 | Adenocarcinoma ... | Bicalutamide (C... | 18 Years - | AstraZeneca | |
| Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | NCT00005044 | Prostate Cancer | Casodex Eulexin LHRH agonist radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Degarelix Neo-Adjuvant Radical Prostatectomy Trial | NCT01674270 | Prostate Cancer | Degarelix Casodex LHRH Agonist | 18 Years - 75 Years | University Health Network, Toronto | |
| Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | NCT00005044 | Prostate Cancer | Casodex Eulexin LHRH agonist radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | NCT00243646 | Prostate Cancer | External beam r... Lupron Casodex | - | Schiffler Cancer Center | |
| Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | NCT01250717 | Prostate Cancer | Docetaxel Dexamethasone Estramustine Zoladex Casodex Radical Prostat... | 18 Years - | Dana-Farber Cancer Institute | |
| Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate | NCT02064036 | Adenocarcinoma ... | Stereotactic Ra... Casodex Leuprolide | 18 Years - | University of California, Davis | |
| Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg | NCT00919477 | Prostate Cancer | - | AstraZeneca | ||
| Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg | NCT00919477 | Prostate Cancer | - | AstraZeneca | ||
| Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | NCT00243646 | Prostate Cancer | External beam r... Lupron Casodex | - | Schiffler Cancer Center | |
| External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | NCT00388804 | Prostate Cancer | Radiation Thera... Bicalutamide Leuprolide Goserelin Flutamide Questionnaire | - | M.D. Anderson Cancer Center | |
| Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment | NCT00165399 | Adenocarcinoma ... Prostate Cancer | Docetaxel Estramustine Casodex Zoladex | 18 Years - | Dana-Farber Cancer Institute | |
| Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX | NCT00590213 | Prostate Cancer | Casodex 150mg Radiotherapy Haematology | 18 Years - | AstraZeneca |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
